Bayzed Health Group Inc announced that its board of directors will convene on 28 August 2026 to consider and approve the interim financial results for the six months ended 30 June 2026. The agenda also allows for the handling of other corporate matters.

The meeting will be chaired by Executive Director Dr. Chen Haoyang. As of the announcement date (18 August 2026), the board comprises five executive directors—Dr. Chen Haoyang, Mr. Lyu Chao, Ms. Xu Xu, Mr. Lu Jizhong and Mr. Feng Yu—alongside three independent non-executive directors: Mr. Chan Hok Leung, Ms. Liu Shuang and Dr. Guo Wei.

The company’s disclosure aligns with Hong Kong listing requirements and ensures timely communication of governance actions related to its forthcoming interim financial statement.